ATE346146T1 - Fibrinmikrokugeln und deren verwendungen - Google Patents
Fibrinmikrokugeln und deren verwendungenInfo
- Publication number
- ATE346146T1 ATE346146T1 AT98948190T AT98948190T ATE346146T1 AT E346146 T1 ATE346146 T1 AT E346146T1 AT 98948190 T AT98948190 T AT 98948190T AT 98948190 T AT98948190 T AT 98948190T AT E346146 T1 ATE346146 T1 AT E346146T1
- Authority
- AT
- Austria
- Prior art keywords
- fibrin
- present
- fibrin microbeads
- provides
- microbeads
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0042—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/16—Particles; Beads; Granular material; Encapsulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C12N5/0075—General culture methods using substrates using microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
- A61F2310/00377—Fibrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/56—Fibrin; Thrombin
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/934,283 US6150505A (en) | 1997-09-19 | 1997-09-19 | Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE346146T1 true ATE346146T1 (de) | 2006-12-15 |
Family
ID=25465299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98948190T ATE346146T1 (de) | 1997-09-19 | 1998-09-15 | Fibrinmikrokugeln und deren verwendungen |
Country Status (8)
Country | Link |
---|---|
US (4) | US6150505A (de) |
EP (1) | EP1015570B1 (de) |
JP (3) | JP2001517431A (de) |
AT (1) | ATE346146T1 (de) |
AU (1) | AU758000B2 (de) |
CA (1) | CA2304384A1 (de) |
DE (1) | DE69836491T2 (de) |
WO (1) | WO1999015637A1 (de) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998012274A1 (en) * | 1996-09-23 | 1998-03-26 | Chandrashekar Pathak | Methods and devices for preparing protein concentrates |
US6150505A (en) * | 1997-09-19 | 2000-11-21 | Hadasit Medical Research Services & Development Ltd. | Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII |
DE19849589C1 (de) * | 1998-10-27 | 2000-06-15 | Glatt Process Technology Gmbh | Fibrin-Gewebekleber-Formulierung und Verfahren zu dessen Herstellung |
US7572769B2 (en) | 1998-12-23 | 2009-08-11 | Csl Behring Gmbh | Fibrin adhesive granulate and method for its preparation |
US7115410B1 (en) * | 1999-02-10 | 2006-10-03 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
JP2003500172A (ja) * | 1999-06-01 | 2003-01-07 | ブリストル−マイヤーズ スクイブ カンパニー | フィブリンポリマー構造体 |
DE19949290A1 (de) * | 1999-10-12 | 2001-04-26 | Albrecht Bettermann | Partikuläres Konstrukt zur Verwendung in der Transplantationsmedizin |
EP1099443A1 (de) * | 1999-11-11 | 2001-05-16 | Sulzer Orthopedics Ltd. | Transplantations/Implantatsvorrichtung und ihre Herstellungsmethode |
GB0008411D0 (en) | 2000-04-05 | 2000-05-24 | Vectura Ltd | Pharmaceutical preparations and their manufacture |
US7144729B2 (en) | 2000-09-01 | 2006-12-05 | Dfb Pharmaceuticals, Inc. | Methods and compositions for tissue regeneration |
WO2002018546A2 (en) * | 2000-09-01 | 2002-03-07 | Virginia Commonwealth University Intellectual Property Foundation | Plasma-derived-fibrin-based matrices and tissue |
AUPR289601A0 (en) * | 2001-02-05 | 2001-03-01 | Commonwealth Scientific And Industrial Research Organisation | Method of tissue repair |
AU2002227792B2 (en) * | 2001-02-05 | 2007-12-13 | Industrial Technology Research Institute | Methods and devices for tissue repair |
US6552172B2 (en) * | 2001-08-30 | 2003-04-22 | Habto Biotech, Inc. | Fibrin nanoparticles and uses thereof |
WO2003041568A2 (en) * | 2001-11-15 | 2003-05-22 | University Of Medicine & Dentistry Of New Jersey | A three-dimensional matrix for producing living tissue equivalents |
US6863660B2 (en) | 2002-03-27 | 2005-03-08 | Hapio Biotech, Inc. | Fibrin applicator pistol |
EP1610829B1 (de) | 2003-04-04 | 2010-01-20 | Tissuemed Limited | Zusammensetzungen für die gewebeadhäsion |
US9526746B2 (en) | 2004-02-13 | 2016-12-27 | Smith & Nephew, Inc. | Wound healing composition |
JP4523311B2 (ja) * | 2004-03-29 | 2010-08-11 | オリンパス株式会社 | 細胞の搬送方法および培養方法 |
BRPI0514106A (pt) * | 2004-08-03 | 2008-05-27 | Tissuemed Ltd | materiais adesivos a tecidos |
AU2006213822B2 (en) | 2005-02-09 | 2011-05-26 | Covidien Lp | Synthetic sealants |
GB0505202D0 (en) | 2005-03-14 | 2005-04-20 | Intercytex Ltd | Skin equivalent culture |
AU2006251004C1 (en) | 2005-05-26 | 2013-05-23 | Intercytex Limited | Tissue repair using allogenic dermal fibroblasts |
CA2610646C (en) * | 2005-06-02 | 2012-09-04 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Prevascularized devices and related methods |
EP1764117A1 (de) | 2005-09-20 | 2007-03-21 | Zimmer GmbH | Implantat zur Wiederherstellung von Knorpeldefekten und Verfahren zu seiner Herstellung |
US20070116680A1 (en) * | 2005-11-18 | 2007-05-24 | Rensselaer Polytechnic Institute | Stem cells within gel microenvironments |
AU2007210879B2 (en) | 2006-02-03 | 2013-01-10 | Tissuemed Limited | Tissue-adhesive materials |
US20090018575A1 (en) * | 2006-03-01 | 2009-01-15 | Tissuemed Limited | Tissue-adhesive formulations |
WO2008097581A1 (en) * | 2007-02-06 | 2008-08-14 | Incept, Llc | Polymerization with precipitation of proteins for elution in physiological solution |
US20090227689A1 (en) * | 2007-03-05 | 2009-09-10 | Bennett Steven L | Low-Swelling Biocompatible Hydrogels |
US20090227981A1 (en) * | 2007-03-05 | 2009-09-10 | Bennett Steven L | Low-Swelling Biocompatible Hydrogels |
WO2009002456A2 (en) * | 2007-06-21 | 2008-12-31 | Massachusetts Institute Of Technology | Methods and compositions relating to progenitor cells |
EP2237806A2 (de) * | 2007-12-26 | 2010-10-13 | Metamorefix | Pulverisierte fibringerinnsel und pharmazeutische zusammensetzungen damit |
DE102008039812A1 (de) | 2008-08-25 | 2010-03-04 | Yvonne Ibold | Vorrichtung und Verfahren zur Kultivierung von adhärenten Zellen |
JP5177774B2 (ja) * | 2008-12-12 | 2013-04-10 | 国立大学法人 東京大学 | 細胞の3次元階層的共培養法 |
CA2750242C (en) | 2009-02-12 | 2018-05-22 | Incept, Llc | Drug delivery through hydrogel plugs |
US8529883B2 (en) * | 2010-05-07 | 2013-09-10 | Fibrocell Technologies, Inc. | Dosage unit formulations of autologous dermal fibroblasts |
US9938501B2 (en) * | 2010-07-28 | 2018-04-10 | Jointechlabs, Inc. | Encapsulated adipose-derived stem cells, methods for preparation and theraputic use |
WO2012088412A2 (en) * | 2010-12-22 | 2012-06-28 | Becton, Dickinson And Company | Capture and enrichment of organisms and cells from liquids |
US10226417B2 (en) | 2011-09-16 | 2019-03-12 | Peter Jarrett | Drug delivery systems and applications |
WO2014016829A1 (en) * | 2012-07-22 | 2014-01-30 | Mx Biotech Ltd. | Insoluble fibrinogen particles (ifp) and coatings : composition, fabrication methods, and applications for harvesting and culturing mammalian cells |
FR3032202B1 (fr) | 2015-02-03 | 2018-12-07 | Maco Pharma | Matrice sous forme de bille comme support cellulaire |
CN107427601B (zh) * | 2015-03-27 | 2021-08-31 | 3M创新有限公司 | 纤维蛋白组合物、方法和伤口用制品 |
US20160303281A1 (en) | 2015-04-17 | 2016-10-20 | Rochal Industries, Llc | Composition and kits for pseudoplastic microgel matrices |
WO2016179588A1 (en) * | 2015-05-07 | 2016-11-10 | President And Fellows Of Harvard College | Dynamic immiscible liquid interfaces for cell sheet detachment |
AU2017230806B2 (en) | 2016-03-10 | 2021-06-24 | Arthrex, Inc. | Systems and methods for preparing a thrombin serum |
CA3013659C (en) | 2016-03-10 | 2023-11-14 | Arthrex, Inc. | Systems and methods for preparing protein enhanced serums |
TWI731108B (zh) * | 2016-06-24 | 2021-06-21 | 徐家祥 | 具有止血功能的醫藥組合物 |
US11827754B2 (en) | 2016-10-05 | 2023-11-28 | 3M Innovative Properties Company | Fibrin composition comprising carrier material, method and wound articles |
US10940233B2 (en) | 2016-10-05 | 2021-03-09 | 3M Innovative Properties Company | Fibrinogen composition, method and wound articles |
WO2018222906A1 (en) | 2017-06-01 | 2018-12-06 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Formation of stable cartilage |
EP3717033A4 (de) | 2017-12-01 | 2021-08-25 | North Carolina State University | Fibrinpartikel und verfahren zu ihrer herstellung |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3663687A (en) * | 1968-06-26 | 1972-05-16 | Minnesota Mining & Mfg | Biodegradable parenteral microspherules |
US3937668A (en) * | 1970-07-15 | 1976-02-10 | Ilse Zolle | Method for incorporating substances into protein microspheres |
CA1077842A (en) * | 1975-10-09 | 1980-05-20 | Minnesota Mining And Manufacturing Company | Albumin medicament carrier system |
FR2470794A1 (fr) * | 1979-12-05 | 1981-06-12 | Pasteur Institut | Nouvelles microparticules, leur preparation et leurs applications en biologie, notamment a la culture de cellules diploides humaines |
US5069936A (en) * | 1987-06-25 | 1991-12-03 | Yen Richard C K | Manufacturing protein microspheres |
US5260420A (en) * | 1987-07-30 | 1993-11-09 | Centre Regional De Transfusion Sanguine De Lille | Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof |
JPH05292899A (ja) * | 1991-06-24 | 1993-11-09 | Ajinomoto Co Inc | マイクロカプセルの製造方法 |
US5272074A (en) * | 1992-04-23 | 1993-12-21 | Mcmaster University | Fibrin coated polymer surfaces |
FR2694895B1 (fr) * | 1992-08-20 | 1994-11-10 | Coletica | Procédé de fabrication de microparticules en émulsion par modification de la composition chimique de la phase dispersée après émulsification. |
FR2694894B1 (fr) * | 1992-08-20 | 1994-11-10 | Coletica | Utilisation d'une réaction de transacylation entre un polysaccharide estérifié et une substance polyaminée ou polyhydroxylée pour la fabrication de microparticules, procédé et composition. |
FR2703927B1 (fr) * | 1993-04-13 | 1995-07-13 | Coletica | Utilisation d'une réaction de transacylation entre un polysaccharide estérifié et une polyamine pour former en milieu aqueux une membrane au moins en surface de particules gélifiées. |
US5637687A (en) * | 1993-08-31 | 1997-06-10 | Wiggins; James C. | Methods and compositions for isolating nucleic acids |
US5411885A (en) * | 1993-12-17 | 1995-05-02 | New York Blood Center, Inc. | Methods for tissue embedding and tissue culturing |
US5783214A (en) * | 1994-06-13 | 1998-07-21 | Buford Biomedical, Inc. | Bio-erodible matrix for the controlled release of medicinals |
WO1998000161A1 (en) * | 1996-05-24 | 1998-01-08 | Buford Biomedical, Inc. | Fibrin-based systems for the controlled release of medicinals |
US5672485A (en) * | 1996-08-13 | 1997-09-30 | Regents Of The University Of Minnesota | Immortalized cell lines for virus growth |
US6150505A (en) * | 1997-09-19 | 2000-11-21 | Hadasit Medical Research Services & Development Ltd. | Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII |
US6552172B2 (en) * | 2001-08-30 | 2003-04-22 | Habto Biotech, Inc. | Fibrin nanoparticles and uses thereof |
-
1997
- 1997-09-19 US US08/934,283 patent/US6150505A/en not_active Expired - Lifetime
-
1998
- 1998-09-15 WO PCT/US1998/019084 patent/WO1999015637A1/en active IP Right Grant
- 1998-09-15 DE DE69836491T patent/DE69836491T2/de not_active Expired - Lifetime
- 1998-09-15 AU AU94815/98A patent/AU758000B2/en not_active Ceased
- 1998-09-15 US US09/153,547 patent/US6503731B2/en not_active Expired - Fee Related
- 1998-09-15 CA CA002304384A patent/CA2304384A1/en not_active Abandoned
- 1998-09-15 AT AT98948190T patent/ATE346146T1/de not_active IP Right Cessation
- 1998-09-15 JP JP2000512930A patent/JP2001517431A/ja active Pending
- 1998-09-15 EP EP98948190A patent/EP1015570B1/de not_active Expired - Lifetime
-
2002
- 2002-10-25 US US10/280,871 patent/US6737074B2/en not_active Expired - Fee Related
-
2004
- 2004-03-17 US US10/802,400 patent/US20040247691A1/en not_active Abandoned
-
2007
- 2007-09-05 JP JP2007230805A patent/JP2008044950A/ja active Pending
-
2008
- 2008-11-07 JP JP2008286886A patent/JP2009114189A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20040247691A1 (en) | 2004-12-09 |
EP1015570B1 (de) | 2006-11-22 |
AU9481598A (en) | 1999-04-12 |
JP2009114189A (ja) | 2009-05-28 |
EP1015570A4 (de) | 2003-08-06 |
JP2008044950A (ja) | 2008-02-28 |
JP2001517431A (ja) | 2001-10-09 |
US6737074B2 (en) | 2004-05-18 |
CA2304384A1 (en) | 1999-04-01 |
DE69836491D1 (de) | 2007-01-04 |
DE69836491T2 (de) | 2007-10-25 |
WO1999015637A1 (en) | 1999-04-01 |
US20030059475A1 (en) | 2003-03-27 |
EP1015570A1 (de) | 2000-07-05 |
US6503731B2 (en) | 2003-01-07 |
AU758000B2 (en) | 2003-03-13 |
US6150505A (en) | 2000-11-21 |
US20020006649A1 (en) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE346146T1 (de) | Fibrinmikrokugeln und deren verwendungen | |
ATE500323T1 (de) | Subtilisin-variante | |
AR053383A2 (es) | Celulas vegetales transformadas, plantas que las contienen y uso de una construccion de adn en un metodo | |
ATE288479T1 (de) | Verfahren fuer die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren | |
DK0527760T3 (da) | Fremgangsmåder og præparater til vaccination mod HIV | |
DK0600866T3 (da) | Præparater og fremgangsmåder til identifikation af biologisk aktive molekyler | |
ATE264863T1 (de) | 28-epirapaloge | |
IT8947794A0 (it) | Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle | |
CO4830493A1 (es) | Anticuerpos contra cd40 humano | |
BR9912662A (pt) | Melhoria de função cardìaca por transplante de célula de ramo mesenquimal | |
IL106248A (en) | Adhesive compositions and method of bonding biological tissue to a substance | |
ATE153214T1 (de) | Medien zur zellzucht und verfahren dazu | |
DE69637844D1 (de) | Neues tgf-beta-ahnliches cytokin | |
PT1318198E (pt) | Processo para produzir um polipeptido recombinante que envolve a adicao de um inibidor de quimotripsina ao meio de cultura celular | |
TR200401091T4 (tr) | Gelişim faktörleri ve L-glutamin içeren hücre kültürü besiyeri | |
DE68916532T3 (de) | Varianten von menschlichem gewebeplasminogenaktivator sowie verfahren zu deren herstellung. | |
AU4279996A (en) | New method for identifying and evaluating biologically active molecules | |
DK0889957T3 (da) | Subtilisindimer med forbedret aktivitet og fremgangsmåde til fremstilling deraf | |
ATE348876T1 (de) | Verfahren zur vermehrung von natürlichen killerzellen | |
DK0775159T3 (da) | Ny fremgangsmåde til fremstilling af biologisk aktivt dimert protein | |
IL157639A0 (en) | Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension | |
DE58906338D1 (de) | Kombination von Angiotensin-Converting-Enzyme-Hemmern mit Kaliumkanal-Modulatoren sowie deren Verwendung in Arzneimitteln. | |
ATE218377T1 (de) | Verfahren zur präparation von knochenmaterial | |
MXPA03009312A (es) | Metodo para trasplante autologo. | |
ES2132027A1 (es) | Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |